Article
A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network
10 Aug 2018
Abstract excerpt
BACKGROUND: Prostate adenocarcinoma (AdPC) cells can undergo lineage switching to neuroendocrine cells and develop into therapy-resistant neuroendocrine prostate cancer (NEPC). While genomic/epigenetic alterations are shown to induce neuroendocrine differentiation via an intermediate stem-like state, RNA splicing factor SRRM4 can transform AdPC cells into NEPC xenografts through a direct neuroendocrine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
